Permanent gold-198 implant for locally recurrent adenocarcinoma of the prostate after failing initial radiotherapy

Journal of Brachytherapy International

Volumn 14, Issue 4, 1998, Pages 233-240

  Teh, B S ^a   Berner, B M ^a   Carpenter, L S ^a   Chiu, J K ^a   Dennis, W S ^a   Lu, H H ^a   Woo, S Y ^a   Butler, E B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Brachytherapy; Gold 198 implant; Recurrent prostate cancer

Indexed keywords

ANTIANDROGEN; GOLD 198; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; HUMAN; INTERSTITIAL RADIATION; MALE; METAL IMPLANTATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RECURRENT CANCER; TREATMENT INDICATION;

EID: 0032405838     PISSN: 10944540     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)